๐ฐ Ernest Hawk News
Page 2 - Ernest Hawk News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ernest Hawk. Real-time updates on events, politics, business and more.
December 17, 2022
U.S. and European antitrust enforcers want to unwind gene sequencing leader Illumina Incs purchase of cancer test company Grail, saying the two would stifle competition in a critical area of... | December 16, 2022
December 16, 2022
Still, he noted "thoughts about their role being diminished in the future is speculative." Esener, who uses gene sequencing machines from Illumina and Pacific Biosciences of California (PacBio) for research looking to detect liver cancer in its earliest stages, noted the field of early cancer detection is diverse, with about 30 companies working on five different methods of testing for signs of very early cancer โ including the types Grail and its rivals are focused on. If proven to...
December 16, 2022
U.S. and European antitrust enforcers want to unwind gene sequencing leader Illumina Incs purchase of cancer test company Grail, saying the two would stifle competition in a critical area of
December 16, 2022
By Deena Beasley and Julie Steenhuysen LOS ANGELES/CHICAGO (Reuters) - U.S. and European antitrust enforcers want to unwind gene sequencing leader Ill...
November 28, 2022
Results of a large, international study show the benefit of annual, low-dose CT scans for those diagnosed early persists at 20 years.
September 19, 2022
But if these tests are used more widely, oncologists will need to navigate a slew of new challenges.
September 16, 2022
/PRNewswire/ -- Today, the National Comprehensive Cancer Networkยฎ (NCCNยฎ) hosted a policy summit to examine practice changes and trends in legislative and...
September 16, 2022
National Comprehensive Cancer Networks #NCCNPolicy Summit, featuring White House Moonshot Coordinator and representatives from CDC, NCI, and USPSTF, examines
April 5, 2022
Some studies have suggested modest amounts are beneficial. Others have linked them to an increased risk of cancer. So, whatโs the verdict on moderate drinking?